Renee D. Gala

2017

In 2017, Renee D. Gala earned a total compensation of $929.5K as SVP and Chief Financial Officer, Treasurer at Theravance Biopharma, a 58% decrease compared to previous year.

Compensation breakdown

Bonus$80,020
Non-Equity Incentive Plan$120,031
Salary$443,305
Stock Awards$281,160
Other$5,000
Total$929,516

Gala received $443.3K in salary, accounting for 48% of the total pay in 2017.

Gala also received $80K in bonus, $120K in non-equity incentive plan, $281.2K in stock awards and $5K in other compensation.

Rankings

In 2017, Renee D. Gala's compensation ranked 9,315th out of 14,666 executives tracked by ExecPay. In other words, Gala earned more than 36.5% of executives.

ClassificationRankingPercentile
All
9,315
out of 14,666
37th
Division
Manufacturing
3,577
out of 5,770
38th
Major group
Chemicals And Allied Products
1,230
out of 2,074
41st
Industry group
Drugs
989
out of 1,730
43rd
Industry
Pharmaceutical Preparations
777
out of 1,329
42nd
Source: SEC filing on March 21, 2018.

Gala's colleagues

We found four more compensation records of executives who worked with Renee D. Gala at Theravance Biopharma in 2017.

2017

Shehnaaz Suliman

Theravance Biopharma

Senior Vice President, Corporate Development and Strategy

2017

Rick Winningham

Theravance Biopharma

Chief Executive Officer

2017

Bradford Shafer

Theravance Biopharma

General Counsel

2017

Frank Pasqualone

Theravance Biopharma

Senior Vice President and Global Head, Acute Care Business

News

You may also like